ConductScience.org, home

Paper23940286

Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.

Ajona D and 13 others. J Natl Cancer Inst, 2013. Cited by 138 papers, by iCite.

Cite this record

ConductScience Library. Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer. Papers, record 23940286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23940286

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
138
iCite
Relative citation ratio, by iCite
3.66
iCite
Revised in PubMed
2022-04-09
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ajona DDaniel
2Pajares MJMaría J
3Corrales LLeticia
4Perez-Gracia JLJose L
5Agorreta JJackeline
6Lozano MDMaria D
7Torre WWenceslao
8Massion PPPierre P
9de-Torres JPJuan P
10Jantus-Lewintre EEloisa
11Camps CCarlos
12Zulueta JJJavier J
13Montuenga LMLuis M
14Pio RRuben

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Bronchoalveolar Lavage FluidMajor topic
Complement C4bMajor topic
Lung NeoplasmsMajor topic
Peptide FragmentsMajor topic
Adult
Aged
Complement Activation
Complement Pathway, Classical
Early Detection of Cancer
Female
Humans
Male
Middle Aged
Neoplasm Staging
Predictive Value of Tests
Prognosis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
U01 CA152662NCI NIH HHSUnited StatesU01CA152662PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11323139Immunoglobulins and complement components levels in patients with lung cancer.Rom J Intern Med1992https://conductscience.org/library/papers/1323139PubMed
217442984Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth.J Immunol2007https://conductscience.org/library/papers/17442984PubMed
318250442C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition.J Immunol2008https://conductscience.org/library/papers/18250442PubMed
4977762Immunoglobulins and complement in pleural effusions associated with bronchogenic carcinoma.J Clin Pathol1976https://conductscience.org/library/papers/977762PubMed
521481963Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC.Lung Cancer2011https://conductscience.org/library/papers/21481963PubMed
621300873MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21300873PubMed
716489012Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.Cancer Res2006https://conductscience.org/library/papers/16489012PubMed
87545058Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract.Am J Respir Crit Care Med1995https://conductscience.org/library/papers/7545058PubMed
916177255Immune response as a biomarker for cancer detection and a lot more.N Engl J Med2005https://conductscience.org/library/papers/16177255PubMed
1023226093Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.Neoplasia2012https://conductscience.org/library/papers/23226093PubMed
1120720586Complement: a key system for immune surveillance and homeostasis.Nat Immunol2010https://conductscience.org/library/papers/20720586PubMed
1217548110Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors.Mol Immunol2008https://conductscience.org/library/papers/17548110PubMed
1321714641Reduced lung-cancer mortality with low-dose computed tomographic screening.N Engl J Med2011https://conductscience.org/library/papers/21714641PubMed
1416395409Differential exoprotease activities confer tumor-specific serum peptidome patterns.J Clin Invest2006https://conductscience.org/library/papers/16395409PubMed
1523028051Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.J Immunol2012https://conductscience.org/library/papers/23028051PubMed
1615342420Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement.Cancer Res2004https://conductscience.org/library/papers/15342420PubMed
179717965
Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
Clin Exp Immunol1998https://conductscience.org/library/papers/9717965PubMed
1822689914The state of molecular biomarkers for the early detection of lung cancer.Cancer Prev Res (Phila)2012https://conductscience.org/library/papers/22689914PubMed
1920802023Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer.Cancer Epidemiol Biomarkers Prev2010https://conductscience.org/library/papers/20802023PubMed
2011739526Specific inhibition of the classical complement pathway by C1q-binding peptides.J Immunol2001https://conductscience.org/library/papers/11739526PubMed

See all 29 referencesDownload CSV of references

Cited by84

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 138 citations.

PMIDTitleJournalYearIn PapersSource
42472420Proteomic characterization of airway obstruction-associated proteins in non-smoking lung adenocarcinoma.Clin Transl Oncol2026https://conductscience.org/library/papers/42472420PubMed
42238034Identification of High-Performing Blood Metabolite Biomarkers of Lung Cancer in a Chinese Population.Phenomics2026https://conductscience.org/library/papers/42238034PubMed
42129855Circulating extracellular vesicles from early-stage lung cancer patients trigger endothelial activation to drive pre-metastatic niche formation through synergistic miR-29a and C4A signaling.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/42129855PubMed
41819546Complement system in cancer: friend or foe of immunotherapy.J Immunother Cancer2026https://conductscience.org/library/papers/41819546PubMed
41526546The contribution of the membrane-bound complement regulatory proteins CD46 and CD55 in phases of acute lymphocytic leukemia and acute myelogenous leukemia.Sci Rep2026https://conductscience.org/library/papers/41526546PubMed
41241678Complement system in tumor growth and metastases.Br J Cancer2026https://conductscience.org/library/papers/41241678PubMed
40950900Biomarkers for the diagnosis of indeterminate pulmonary nodules: are we there yet?J Thorac Dis2025https://conductscience.org/library/papers/40950900PubMed
40777024Identification of a coagulation-related classification and signature that predict disease heterogeneity for colorectal cancer and pan-cancer patients.Front Immunol2025https://conductscience.org/library/papers/40777024PubMed
40698088Complement and coagulation cascade cross-talk in endometriosis and the potential of Janus Kinase inhibitors-a network meta-analysis.Front Immunol2025https://conductscience.org/library/papers/40698088PubMed
40622549Role of Innate Immunity in Cancer.Adv Exp Med Biol2025https://conductscience.org/library/papers/40622549PubMed
40612949Impact of smoking on the complement system: a narrative review.Front Immunol2025https://conductscience.org/library/papers/40612949PubMed
40492591O-GalNAc Glycosylation Activates MBL-Mediated Complement and Coagulation Cascades to Drive Organotropic Metastasis.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40492591PubMed
40210889Genetically druggable targets for MAPK-activated colorectal cancer by a two-sample mendelian randomization analysis.Sci Rep2025https://conductscience.org/library/papers/40210889PubMed
39764857Prognostic significance of serum complement activation, neutrophil extracellular traps and extracellular DNA in newly diagnosed epithelial ovarian cancer.Gynecol Oncol2025https://conductscience.org/library/papers/39764857PubMed
39239051Complement protein expression changes in various conditions of breast cancer: in-silico analyses-experimental research.Ann Med Surg (Lond)2024https://conductscience.org/library/papers/39239051PubMed
39036305Activation of the complement system sensitizes immune checkpoint blockade.J Natl Cancer Cent2023https://conductscience.org/library/papers/39036305PubMed
38881920Comprehensive proteomic profiling of lung adenocarcinoma: development and validation of an innovative prognostic model.Transl Cancer Res2024https://conductscience.org/library/papers/38881920PubMed
38375474Tea intake and lung diseases: a Mendelian randomization study.Front Immunol2024https://conductscience.org/library/papers/38375474PubMed
38025810Biomarkers of lung cancer for screening and in never-smokers-a narrative review.Transl Lung Cancer Res2023https://conductscience.org/library/papers/38025810PubMed
37396553Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics.Genes Dis2023https://conductscience.org/library/papers/37396553PubMed

See all 84 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C1QA712PubTator's text mininghttps://conductscience.org/library/genes/712NCBI Gene
C4B721PubTator's text mininghttps://conductscience.org/library/genes/721NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23940286

GET https://conductscience.org/api/papers/v1/23940286/references?page=2